Ozempic® 0.5 mg is a once-weekly prescription medication containing semaglutide, a GLP-1 receptor agonist used to help adults with type 2 diabetes improve blood sugar control when combined with a healthy diet and regular exercise. The 0.5 mg dose is commonly prescribed after the initial 0.25 mg starting dose and serves as a maintenance dose for many patients. Ozempic also helps reduce appetite, which may support weight loss in some individuals, although it is not approved solely for weight management. Additionally, it has been shown to reduce the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease.
Key Benefits
- Once-weekly injection
- Helps lower blood sugar (HbA1c)
- May promote weight loss by reducing appetite
- Supports long-term diabetes management
- May reduce the risk of heart attack, stroke, and certain kidney complications in eligible patients
Important Information
Ozempic should only be used under the supervision of a qualified healthcare provider. It is not intended for people with type 1 diabetes or diabetic ketoacidosis and may not be suitable for individuals with certain medical conditions. Common side effects include nausea, vomiting, diarrhea, constipation, and stomach discomfort, which often improve as treatment continues.
Reviews
There are no reviews yet.